arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Airsculpt Technologies, Inc.

AIRS
$2.16 ▼ -0.37 (-14.62%) at close
Industrials ·Services-Offices & Clinics of Doctors of Medicine ·USServices-Offices & Clinics of Doctors of Medicine
23 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Bearish
auto_awesome

Analytical Summary

Airsculpt Technologies, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $152.9M
Dividend Yield —
Revenue Growth -2.5% ↘
Op. Margin -0.1% ↗
ROIC -0.0% ↗
FCF / Share $-0.02 ↘
Trailing P/E —
Price / Book 1.5x
FCF Yield —
Debt / Equity 0.42
info Valuation on last close. End-of-day price, Sep 23, 2026.

23-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$42.90M
↓ -2.5% —
Net Income Profit after all expenses
$-2.40M
↑ +15.8% —
Operating Margin Operating profit as % of sales
-0.1%
↑ +98.5% 17th
FCF / Share Free cash flow per share
$-0.02
↓ -127.6% —
Long-Term Debt Long-term obligations
$43.57M
↓ -2.8% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
21
Returns
32
Financial Health ↓
42
Cash Quality
20

Dividend History

Dividend / share · sourced from SEC filings
$0.41 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 23 quarters